Quanterix (QTRX) Asset Writedowns and Impairment (2021 - 2026)
Quanterix posted quarterly Asset Writedowns and Impairment of $305000.0 for Q1 2026, up 475.47% year-on-year from $53000.0 in Q1 2025, and down 95.92% on a QoQ basis from $7.5 million in Q4 2025.
Quanterix (QTRX) has 6 years of Asset Writedowns and Impairment data on file, last reported at $305000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 475.47% year-over-year to $305000.0; the trailing twelve-month figure through Mar 2026 stood at $8.4 million (up 1371.48% YoY), and the FY2025 full-year result was $7.8 million, up 1218.37% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $305000.0, down from $7.5 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $8.7 million in Q3 2022 and bottomed at -$403000.0 in Q4 2022.
- The 5-year median for Asset Writedowns and Impairment is $146000.0 (2023), against an average of $1.1 million.
- The widest annual swing landed in 2022, when Asset Writedowns and Impairment slumped 955.0%; it then surged 4887.18% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at -$403000.0 in 2022, then soared by 360.55% to $1.0 million in 2023, then slumped by 114.86% to -$156000.0 in 2024, then soared by 4887.18% to $7.5 million in 2025, then slumped by 95.92% to $305000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $305000.0 (Q1 2026), $7.5 million (Q4 2025), and $900000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305,000.00 |
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 7.47 Mn |
| Dec 31, 2025 | 7.47 Mn |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Dec 31, 2024 | -156,000.00 |
| Dec 31, 2024 | -156,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 603,000.00 |
| Jun 30, 2024 | 603,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | -13,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 146,000.00 |
| Mar 31, 2023 | 178,000.00 |
| Mar 31, 2023 | 178,000.00 |
| Dec 31, 2022 | -403,000.00 |
| Dec 31, 2022 | -403,000.00 |
| Sep 30, 2022 | 8.70 Mn |
| Sep 30, 2022 | 8.70 Mn |
| Jun 30, 2022 | 378,000.00 |
| Jun 30, 2022 | 378,000.00 |
| Mar 31, 2022 | -171,000.00 |
| Mar 31, 2022 | -171,000.00 |
| Dec 31, 2021 | -286,000.00 |
| Dec 31, 2021 | -286,000.00 |
| Sep 30, 2021 | 266,000.00 |
| Sep 30, 2021 | 266,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Mar 31, 2021 | 20,000.00 |